Avid Radiopharmaceuticals, Inc. Expands R&D Capabilities with Appointment of Dr. Mark A. Mintun as Chief Medical Officer
8/10/2010 8:40:36 AM
PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc. announced today the appointment of Dr. Mark A. Mintun to the newly created position of Chief Medical Officer. Dr. Mintun brings extensive research, clinical and management experience to Avid, most recently serving as Vice Chair for Research and Director of the Center for Clinical Imaging Research at the prestigious Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, MO. Dr. Mintun will report to Avid’s President and CEO, Daniel M. Skovronsky, M.D., Ph.D.
comments powered by